3D printing to be utilised by three quarters of Europe’s SMB’s by 2020

By Sean Galea-Pace
Share
Following new research by Ricoh Europe, it has been revealed that almost three quarters of Europe’s small and medium sized businesses (SMB) believe th...

Following new research by Ricoh Europe, it has been revealed that almost three quarters of Europe’s small and medium sized businesses (SMB) believe that 3D printing technology is vital to reduce costs and improve agility.

The research found that 44% of the 2,370 SMB leaders surveyed from 23 different countries have already invested in 3D printing with a further 30% planning to invest within the next two years.

From the businesses that were surveyed, it was revealed that 70% of businesses are aiming to utilise 3D printing to introduce new manufacturing strategies and techniques.

See more:

It was also noted in the findings that 80% of SMBs are expecting to produce 3D printing into their product development cycles with 56% hoping to utilise the technology to decrease the cost of storage, shipping and materials by printing products for customers-on-demand.

“New forms of print are levelling the playing field for SMBs,” said David Mills, CEO of Ricoh Europe.

“By helping to mitigate production and development issues, smart organisations are using 3D printing to remove some of the key obstacles they often encounter within their supply chains or when competing with larger rivals. This is critical for any firm looking to scale and establish a stronger presence in the market.”

Share

Featured Articles

Axiado & Pegatron Partner to Boost Server Security

Axiado and Pegatron's collaboration enhances server security for manufacturing, delivering robust AI-driven protection for modern industrial data centres

Genus Power Showcases Smart Metering Innovation & Diversity

Genus Power impresses US delegation with cutting-edge smart metering technology and a diverse workforce, advancing global clean energy solutions

Telix's bid to Expand Access to Cancer Radiopharmaceuticals

Rhine Pharma, spun off by Telix, aims to open production to improve worldwide access to radiopharmaceuticals for cancer imaging & treatment

UK Automotive Manufacturers Face Net Zero Challenge

Sustainability & ESG

Samsung Biologics Secures US$1.24Bn Manufacturing Deal

Production & Operations

How is ABB Revolutionising Automotive Sustainability?

Sustainability & ESG